Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135294003> ?p ?o ?g. }
- W3135294003 abstract "Background: Acute respiratory distress syndrome (ARDS) is a clinical presentation of acute lung injury (ALI) with often fatal lung complication. Adenosine, a nucleoside generated following cellular stress provides protective effects in acute injury. The levels of extracellular adenosine can be depleted by equilibrative nucleoside transporters (ENTs). ENT inhibition by pharmaceutical agent dipyridamole promotes extracellular adenosine accumulation and is protective in ARDS. However, the therapeutic potential of dipyridamole in acute lung injury has not yet been evaluated. Methods: Adenosine acts on three adenosine receptors, the adenosine A1 (Adora1), A2a (Adora2a), the A2b (Adora2b) or the adenosine A3 (Adora 3) receptor. Accumulation of adenosine is usually required to stimulate the low-affinity Adora2b receptor. In order to investigate the effect of adenosine accumulation and the contribution of epithelial-specific ENT2 or adora2b expression in experimental ALI, dipyridamole, and epithelial specific ENT2 or Adora2b deficient mice were utilized. MLE12 cells were used to probe downstream Adora2b signaling. Adenosine receptors, transporters, and targets were determined in ARDS lungs. Results: ENT2 is mainly expressed in alveolar epithelial cells and is negatively regulated by hypoxia following tissue injury. Enhancing adenosine levels with ENT1/ENT2 inhibitor dipyridamole at a time when bleomycin-induced ALI was present, reduced further injury. Mice pretreated with the ADORA2B agonist BAY 60-6583 were protected from bleomycin-induced ALI by reducing vascular leakage (558.6 ± 50.4 vs. 379.9 ± 70.4, p < 0.05), total bronchoalveolar lavage fluid cell numbers (17.9 ± 1.8 to 13.4 ± 1.4 e4, p < 0.05), and neutrophil infiltration (6.42 ± 0.25 vs. 3.94 ± 0.29, p < 0.05). While mice lacking Adora2b in AECs were no longer protected by dipyridamole. We also identified occludin and focal adhesion kinase as downstream targets of ADORA2B, thus providing a novel mechanism for adenosine-mediated barrier protection. Similarly, we also observed similar enhanced ADORA2B (3.33 ± 0.67 to 16.12 ± 5.89, p < 0.05) and decreased occludin (81.2 ± 0.3 to 13.3 ± 0.4, p < 0.05) levels in human Acute respiratory distress syndrome lungs. Conclusion: We have highlighted a role of dipyridamole and adenosine signaling in preventing or treating ALI and identified Ent2 and Adora2b as key mediators in important for the resolution of ALI." @default.
- W3135294003 created "2021-03-15" @default.
- W3135294003 creator A5001509341 @default.
- W3135294003 creator A5004984762 @default.
- W3135294003 creator A5007017045 @default.
- W3135294003 creator A5027793977 @default.
- W3135294003 creator A5055159691 @default.
- W3135294003 creator A5058022497 @default.
- W3135294003 creator A5058915328 @default.
- W3135294003 creator A5063995996 @default.
- W3135294003 creator A5070127090 @default.
- W3135294003 creator A5083713149 @default.
- W3135294003 date "2021-03-10" @default.
- W3135294003 modified "2023-10-13" @default.
- W3135294003 title "Enhancing Extracellular Adenosine Levels Restores Barrier Function in Acute Lung Injury Through Expression of Focal Adhesion Proteins" @default.
- W3135294003 cites W131207691 @default.
- W3135294003 cites W1490751684 @default.
- W3135294003 cites W1526801414 @default.
- W3135294003 cites W1600560134 @default.
- W3135294003 cites W1803784511 @default.
- W3135294003 cites W180620693 @default.
- W3135294003 cites W1903577729 @default.
- W3135294003 cites W1969675688 @default.
- W3135294003 cites W1979412100 @default.
- W3135294003 cites W1980611128 @default.
- W3135294003 cites W1989468278 @default.
- W3135294003 cites W1991940875 @default.
- W3135294003 cites W1993324234 @default.
- W3135294003 cites W1993750434 @default.
- W3135294003 cites W2002566701 @default.
- W3135294003 cites W2003483275 @default.
- W3135294003 cites W2007023644 @default.
- W3135294003 cites W2009978175 @default.
- W3135294003 cites W2010061071 @default.
- W3135294003 cites W2015232280 @default.
- W3135294003 cites W2016493507 @default.
- W3135294003 cites W2024221619 @default.
- W3135294003 cites W2027812057 @default.
- W3135294003 cites W2033019676 @default.
- W3135294003 cites W2039765075 @default.
- W3135294003 cites W2040652493 @default.
- W3135294003 cites W2040716650 @default.
- W3135294003 cites W2061583677 @default.
- W3135294003 cites W2064640058 @default.
- W3135294003 cites W2067223216 @default.
- W3135294003 cites W2071775013 @default.
- W3135294003 cites W2078544167 @default.
- W3135294003 cites W2082083390 @default.
- W3135294003 cites W2086809028 @default.
- W3135294003 cites W2090368102 @default.
- W3135294003 cites W2091289020 @default.
- W3135294003 cites W2091972503 @default.
- W3135294003 cites W2093852073 @default.
- W3135294003 cites W2097801564 @default.
- W3135294003 cites W2104813562 @default.
- W3135294003 cites W2105135885 @default.
- W3135294003 cites W2105259666 @default.
- W3135294003 cites W2106319656 @default.
- W3135294003 cites W2112508887 @default.
- W3135294003 cites W2115144902 @default.
- W3135294003 cites W2117207639 @default.
- W3135294003 cites W2126084527 @default.
- W3135294003 cites W2129057519 @default.
- W3135294003 cites W2129153922 @default.
- W3135294003 cites W2130202913 @default.
- W3135294003 cites W2131584528 @default.
- W3135294003 cites W2131609320 @default.
- W3135294003 cites W2132238025 @default.
- W3135294003 cites W2138318387 @default.
- W3135294003 cites W2139311294 @default.
- W3135294003 cites W2141035582 @default.
- W3135294003 cites W2143112755 @default.
- W3135294003 cites W2145142784 @default.
- W3135294003 cites W2157676190 @default.
- W3135294003 cites W2159756628 @default.
- W3135294003 cites W2159763561 @default.
- W3135294003 cites W2163501588 @default.
- W3135294003 cites W2164401231 @default.
- W3135294003 cites W2166798770 @default.
- W3135294003 cites W2172292577 @default.
- W3135294003 cites W2397867274 @default.
- W3135294003 cites W2620241325 @default.
- W3135294003 cites W2911278288 @default.
- W3135294003 cites W3016535995 @default.
- W3135294003 cites W3020992950 @default.
- W3135294003 cites W3023822056 @default.
- W3135294003 cites W3047227369 @default.
- W3135294003 cites W3087321968 @default.
- W3135294003 cites W3216587808 @default.
- W3135294003 cites W4206582578 @default.
- W3135294003 cites W4230551284 @default.
- W3135294003 cites W4246675815 @default.
- W3135294003 cites W4250417345 @default.
- W3135294003 cites W4294183732 @default.
- W3135294003 cites W4294658238 @default.
- W3135294003 doi "https://doi.org/10.3389/fmolb.2021.636678" @default.
- W3135294003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7987656" @default.
- W3135294003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33778007" @default.
- W3135294003 hasPublicationYear "2021" @default.
- W3135294003 type Work @default.